Zhejiang Jingxin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions. The Company recently received a letter from Ping An Securities Co., Ltd. (hereinafter referred to as "Ping An Securities") regarding the change of its continuous supervision sponsor representative. Ping An Securities is the sponsor institution for the Company's non-public offering of shares in 2020. The original continuous supervision sponsor representative, Ms. Wang Ying, will no longer be re
002020SZSE
Announcement on the Change of Continuous Supervision Sponsor Representative
✨ AI Summary
Zhejiang Jingxin Pharmaceutical Co., Ltd. has announced the replacement of its continuous supervision sponsor representative. Ms. Wang Ying is no longer responsible for the role due to a job change, and Mr. Long Jiaxi has been appointed as her successor. This change will not affect the ongoing supervision work by Ping An Securities. The board expresses gratitude for Ms. Wang's contributions during her tenure.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.